Wall Street analysts predict that Procter & Gamble Co (NYSE:PG) will report $1.21 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Eight analysts have made estimates for Procter & Gamble’s earnings. The lowest EPS estimate is $1.19 and the highest is $1.23. Procter & Gamble posted earnings of $1.19 per share in the same quarter last year, which would suggest a positive year over year growth rate of 1.7%. The firm is scheduled to announce its next quarterly earnings results on Tuesday, January 22nd.

According to Zacks, analysts expect that Procter & Gamble will report full year earnings of $4.41 per share for the current fiscal year, with EPS estimates ranging from $4.35 to $4.45. For the next financial year, analysts forecast that the company will report earnings of $4.71 per share, with EPS estimates ranging from $4.60 to $4.84. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Procter & Gamble.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 19th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.09 by $0.03. Procter & Gamble had a return on equity of 21.20% and a net margin of 15.10%. The firm had revenue of $16.69 billion during the quarter, compared to the consensus estimate of $16.45 billion. During the same quarter in the previous year, the business earned $1.09 earnings per share. The firm’s quarterly revenue was up .2% compared to the same quarter last year.

A number of research firms have issued reports on PG. Jefferies Financial Group reissued a “hold” rating and set a $86.00 price target on shares of Procter & Gamble in a research report on Friday, November 9th. TD Securities reissued a “hold” rating on shares of Procter & Gamble in a research report on Thursday, November 8th. Bank of America boosted their price target on Procter & Gamble from $92.00 to $95.00 and gave the company a “neutral” rating in a research report on Tuesday, November 6th. ValuEngine raised Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Wednesday, October 24th. Finally, Zacks Investment Research raised Procter & Gamble from a “sell” rating to a “hold” rating in a research report on Wednesday, October 24th. One analyst has rated the stock with a sell rating, fourteen have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $88.38.

PG stock traded down $0.30 during trading on Wednesday, reaching $93.52. 353,144 shares of the stock traded hands, compared to its average volume of 12,890,679. Procter & Gamble has a 52-week low of $70.73 and a 52-week high of $94.81. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.40. The company has a market cap of $236.52 billion, a PE ratio of 22.25, a price-to-earnings-growth ratio of 3.08 and a beta of 0.37.

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 15th. Investors of record on Friday, October 19th were issued a $0.7172 dividend. This represents a $2.87 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date was Thursday, October 18th. Procter & Gamble’s dividend payout ratio is currently 68.01%.

In related news, Chairman David S. Taylor sold 21,029 shares of the stock in a transaction dated Wednesday, August 22nd. The stock was sold at an average price of $83.52, for a total value of $1,756,342.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary A. Coombe sold 10,992 shares of the stock in a transaction dated Wednesday, November 14th. The shares were sold at an average price of $93.90, for a total value of $1,032,148.80. Following the completion of the transaction, the insider now directly owns 64,247 shares of the company’s stock, valued at approximately $6,032,793.30. The disclosure for this sale can be found here. Insiders sold 494,352 shares of company stock valued at $44,961,608 in the last three months. 1.84% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Whitener Capital Management Inc. raised its stake in Procter & Gamble by 4.4% during the second quarter. Whitener Capital Management Inc. now owns 25,952 shares of the company’s stock valued at $2,025,000 after buying an additional 1,084 shares in the last quarter. Blue Fin Capital Inc. raised its stake in Procter & Gamble by 4.7% during the second quarter. Blue Fin Capital Inc. now owns 16,125 shares of the company’s stock valued at $1,259,000 after buying an additional 717 shares in the last quarter. IHT Wealth Management LLC raised its stake in Procter & Gamble by 6.1% during the first quarter. IHT Wealth Management LLC now owns 16,982 shares of the company’s stock valued at $1,314,000 after buying an additional 981 shares in the last quarter. Cypress Capital Management LLC raised its position in shares of Procter & Gamble by 12.6% during the 2nd quarter. Cypress Capital Management LLC now owns 141,219 shares of the company’s stock worth $11,024,000 after purchasing an additional 15,785 shares during the period. Finally, Garland Capital Management Inc. raised its position in shares of Procter & Gamble by 1.3% during the 2nd quarter. Garland Capital Management Inc. now owns 57,592 shares of the company’s stock worth $4,495,000 after purchasing an additional 730 shares during the period. Hedge funds and other institutional investors own 58.57% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Featured Story: Dividend Aristocrat Index

Get a free copy of the Zacks research report on Procter & Gamble (PG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.